Agents with a dominant or highly significant cannabinergic pathway(s) modulating mechanism of action
Optimized Extract - Cannabinoid Receptor Modulation/Endocannabinoid Modulation Research CBRM-OX is a Scientifically Engineered Cannabinoid Receptor/Endocannabinoid Modulator (CB1R/CB2R agonist dominant) Extract.~Indications for anxiolytic, analgesic, antidepressant, myorelaxant, antiemetic, neuroprotective, antiepileptic, immunomodulatory,...
N-Palmitoylethanolamide displays potent efficacy within relieving pain, depression, anxiety, and other debilitating conditions. Research Indications: Analgesic Research (Neuropathic, Chronic, Anti-Inflammatory), Antidepressant Research, Anxiolytic Research, Neurogenic/Neuroprotectant Research, Anti-Cancer Research
CBSA-OX Guided Scientifically Engineered Cannabinoid Receptor-2 (CB2R) Selective Agonist CBSA-OX is a highly potent and selective CB2R agonist (main active: K(i)=89nM). Research Indications: Cannbinergic/CB2R research, Analgesia, Antidepressant, Anti-Cancer, and Anxiolytic research.
Rimonabant is a potent CB1R inverse agonist demonstrating significant anti-obesity and anti-addiction effects, as well as calorie restriction mimetic (CRM) anti-aging capacities. Research Indications: Anti-obesity, Anti-aging, and Anti-addiction (smoking cessation, et al.) research.
URB597 is a potent, orally bioavailable FAAH inhibitor. URB597 inhibits hydrolysis of FAAH metabolized substrates within the endocannabinoid and related systems invoking a parallel increase in brain anandamide, OEA, and PEA. Efficacy on parameters of mood, anxiety, and analgesia with no demonstration of adverse effects.